Enveric Biosciences Inc (ENVB)

Finanzdaten der Enveric Biosciences Inc-Aktie (ENVB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	3.03	-	1.87	2.52	2.19
Research and Development	1.36	-	0.40	1.26	0.75
Depreciation and Amortization	1.11%0.04	0.04	0.04	0.04	0.08
Operating Income/Loss	85.37%-3.03	-1.63	-1.87	-2.52	-2.19
Net Interest Income/Expense	3.63%-0.00	-0.00	0.00	-0.00	0.00
Nonoperating Income/Loss	3.63%-0.00	-0.00	0.00	-0.00	0.00
Income/Loss From Continuing Operations Before Tax	85.36%-3.03	-1.63	-1.87	-2.52	-2.18
	85.36%-3.03	-1.63	-1.87	-2.52	-2.18
Attributable To Parent	85.36%-3.03	-1.63	-1.87	-2.52	-2.18
Basic Average Shares	163.98%3.99	1.51	0.31	2.60	1.80
Diluted Average Shares	163.98%3.99	1.51	0.31	2.60	1.80
Basic Earnings Per Share	29.63%-0.76	-1.08	-10.81	-0.97	-1.22
Diluted Earnings Per Share	29.63%-0.76	-1.08	-10.81	-0.97	-1.22